Latest Headlines
-
Accumold Reaches 7000 Projects Milestone
4/8/2024
Accumold, a leading micro molding expert and innovator, is proud to announce that it has embarked upon its 7000th customer project since its founding in 1985.
-
SMC Ltd. Announces Expansion Of Sterile Fill Finish Capabilities, Unveiling State-Of-The-Art Facility In North Carolina
3/13/2024
SMC Ltd., the worldwide contract manufacturer of single use and disposable medical devices, has today announced the acquisition of an end-to-end fill/finish facility in Charlotte, North Carolina. The facility enables SMC to offer a wider portfolio of services to its pharma clients including lab-to-market development, analytical services, device manufacture, fill/finish, final assembly, and secondary packaging.
-
Bringing Engineering, Clinical Study Expertise To A New Collaboration
3/8/2024
Battelle, the world’s largest independent, non-profit R&D company, and Spark Biomedical, Inc., a Dallas-based pioneer in wearable neurostimulation technologies are collaborating on the development of a non-invasive device to tackle the harmful effects of Acute Stress Reactions (ASR).
-
Aprecia And Battelle Are Impacting The Pharmaceutical Industry Through 3D Printing Innovation
3/8/2024
Aprecia, a precision drug delivery company, has partnered with the research and development experts at Battelle to develop groundbreaking 3D printing platforms with the potential to transform the way medicines are developed, manufactured, distributed, and administered.
-
Allegheny Performance PlasticsĀ® Launches Into Healthcare Sector
3/5/2024
To meet the growing needs of the healthcare industry, Allegheny Performance Plastics is proud to announce the addition of clean and white room environments, including a dedicated automated work cell to be completed later this year.
-
Freudenberg Medical Establishes Second Production Facility In Costa Rica
2/15/2024
Freudenberg Medical, a global contract design and manufacturing (CDMO) partner to the medical device and biopharma industry with facilities in key industry hubs across the Americas, Europe and Asia, announced it is to establish a second manufacturing site in Costa Rica. With this $25 million investment the company is expanding its technologies to deliver increasingly complex products to its global customer base.
-
Novo Holdings To Acquire CDMO Catalent Pharma Solutions For $16.5 Billion
2/5/2024
Catalent, Inc. (NYSE: CTLT), a leader in enabling the development and supply of better treatments for patients worldwide, and Novo Holdings, a holding and investment company that is responsible for managing the assets and wealth of the Novo Nordisk Foundation, today announced that they have entered into a merger agreement under which Novo Holdings will acquire Catalent in an all-cash transaction that values Catalent at $16.5 billion on an enterprise value basis.
-
Aseptic Excellence: Microbiological Validation Seminar Announced For March 14th In Austria
2/2/2024
Aseptic manufacturing for pharmaceutical and biopharmaceutical products is being regulated and standardized as this practice continues to grow in the industry. With the publication of EU Annex 1 in Europe, there are strict guidelines to assure compliance of the aseptic process.
-
Solesis To Open First Manufacturing Site In Costa Rica Dedicated To Custom Polymer And Textile Healthcare Solutions
2/2/2024
The site will expand capabilities to enable development in the fast-growing cardiovascular and advanced therapy markets.
-
Rob Albert Appointed Chief Executive Officer Of B. Braun Of America Inc.
1/26/2024
The Board of Directors of B. Braun of America Inc. (“B. Braun of America”) announced today that they have appointed Rob Albert as Chief Executive Officer of B. Braun of America, succeeding Jean-Claude Dubacher who is taking on global management responsibilities, while remaining Chairman of the Board of B. Braun of America. Albert’s appointment will be effective April 1, 2024.